Embryonal rhabdomyosarcoma with metastases confined to the lungs: Report from the CWS Study Group

Pediatric Blood and Cancer

Volumn 56, Issue 5, 2011, Pages 725-732

  Dantonello, Tobias M ^a   Winkler, Peter ^a   Boelling, Tobias ^b   Friedel, Godehard ^c   Schmid, Irene ^d   Mattke, Adrian C ^e   Ljungman, Gustaf ^f   Bielack, Stefan S ^a,g   Klingebiel, Thomas ^h   Koscielniak, Ewa ^a,i  

^a OLGAHOSPITAL   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c Klinik Schillerhoehe   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e ROYAL CHILDREN'S HOSPITAL   (Australia)

^f UPPSALA UNIVERSITY   (Sweden)

^g UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^h GOETHE UNIVERSITY   (Germany)

ⁱ UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Embryonal rhabdomyosarcoma; Lung metastases; Sarcoma

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IDARUBICIN; IFOSFAMIDE; TROFOSFAMIDE; VINCRISTINE;

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG MEGADOSE; EMBRYONAL RHABDOMYOSARCOMA; FEMALE; HUMAN; INFANT; LUNG METASTASECTOMY; LUNG METASTASIS; LUNG SURGERY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; TREATMENT FAILURE;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; INTERNATIONAL AGENCIES; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; RHABDOMYOSARCOMA, EMBRYONAL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79952158823     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22862     Document Type: Article

References (33)

1. Weihkopf T, Blettner M, Dantonello T, et al. Incidence and time trends of soft tissue sarcomas in German children 1985-2004 - a report from the population-based German childhood cancer registry. Eur J Cancer 2008;44:432-440.
2. Koscielniak E, Harms D, Henze G, et al. Results of treatment for soft tissue sarcoma in childhood and adolescence: A final report of the German cooperative soft tissue sarcoma study cws-86. J Clin Oncol 1999;17:3706-3719.
3. Dantonello TM, Int-Veen C, Harms D, et al. Cooperative trial cws-91 for localized soft tissue sarcoma in children, adolescents, and young adults. J Clin Oncol 2009;27:1446-1455.
4. Flamant F, Rodary C, Rey A, et al. Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the international society of paediatric oncology: Mmt84. Eur J Cancer 1998;34:1050-1062.
5. Crist WM, Anderson JR, Meza JL, et al. Intergroup rhabdomyosarcoma study-IV: Results for patients with nonmetastatic disease. J Clin Oncol 2001;19:3091-3102.
6. Oberlin O, Rey A, Lyden E, et al. Prognostic factors in metastatic rhabdomyosarcomas: Results of a pooled analysis from United States and European cooperative groups. J Clin Oncol 2008;26:2384-2389.
7. Carli M, Colombatti R, Oberlin O, et al. European intergroup studies (mmt 4-89 and mmt4-91) on childhood metastatic rhabdomyosarcoma: Final results and analysis of prognostic factors. J Clin Oncol 2004;22:4735-4742.
8. Crist W, Gehan EA, Ragab AH, et al. The third intergroup rhabdomyosarcoma study. J Clin Oncol 1995;13:610-630.
9. Koscielniak E, Handgretinger R, Dilloo D, et al. Definition of high risk patients: The ebmt-cws experience and cws proposal for a therapeutic strategy for high risk sarcoma patients. Bone Marrow Transplant 2002;30:33-34.
10. Breneman JC, Lyden E, Pappo AS, et al. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma - a report from the intergroup rhabdomyosarcoma study IV. J Clin Oncol 2003;21:78-84.
11. Koscielniak E, Rodary C, Flamant F, et al. Metastatic rhabdomyosarcoma and histologically similar tumors in childhood: A retrospective European multi-center analysis. Med Pediatr Oncol 1992;20:209-214.
12. Koscielniak E, Jurgens H, Winkler K, et al. Treatment of soft tissue sarcoma in childhood and adolescence. A report of the German cooperative soft tissue sarcoma study. Cancer 1992;70:2557-2567.
13. Klingebiel T, Boos J, Beske F, et al. Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: Report of the hd cws-96 trial. Pediatr Blood Cancer 2008;50:739-745.
14. Dantonello TM, Int-Veen C, Winkler P, et al. Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcoma. J Clin Oncol 2008;26:406-413.
15. Harmer MH. Tnm classification of pediatric tumors. Geneva: Union International contre le Cancer; 1982. pp. 23-28.
16. Kaplan EL, Meyer P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
17. Rodeberg D, Arndt C, Breneman J, et al. Characteristics and outcomes of rhabdomyosarcoma patients with isolated lung metastases from IRS-IV. J Pediatr Surg 2005;40:256-262; discussion 262.
18. Raney RB, Jr., Tefft M, Maurer HM, et al. Disease patterns and survival rate in children with metastatic soft-tissue sarcoma. A report from the intergroup rhabdomyosarcoma study (IRS)-I. Cancer 1988;62:1257-1266.
19. Raney B, Anderson J, Breneman J, et al. Results in patients with cranial parameningeal sarcoma and metastases (stage 4) treated on intergroup rhabdomyosarcoma study group (IRSG) protocols II-IV, 1978-1997: Report from the children's oncology group. Pediatr Blood Cancer 2008;51:17-22.
20. Maurer HM, Beltangady M, Gehan EA, et al. The intergroup rhabdomyosarcoma study-I. A final report. Cancer 1988;61:209-220.
21. Prestwich RJ, Picton SV, Glaser A, et al. Fatal pneumonitis in children with metastatic rhabdomyosarcoma following whole lung radiotherapy and sequential epirubicin. Pediatr Blood Cancer 2007;48:586-590.
22. Whelan JS, Burcombe RJ, Janinis J, et al. A systematic review of the role of pulmonary irradiation in the management of primary bone tumours. Ann Oncol 2002;13:23-30.
23. Bolling T, Schuck A, Paulussen M, et al. Whole lung irradiation in patients with exclusively pulmonary metastases of ewing tumors. Toxicity analysis and treatment results of the eicess-92 trial. Strahlenther Onkol 2008;184:193-197.
24. Bolling T, Konemann S, Ernst I, et al. Late effects of thoracic irradiation in children. Strahlenther Onkol 2008;184:289-295.
25. Mertens AC, Yasui Y, Liu Y, et al. Pulmonary complications in survivors of childhood and adolescent cancer. A report from the childhood cancer survivor study. Cancer 2002;95:2431-2441.
26. Weiner DJ, Maity A, Carlson CA, et al. Pulmonary function abnormalities in children treated with whole lung irradiation. Pediatr Blood Cancer 2006;46:222-227.
27. Tukenova M, Guibout C, Oberlin O, et al. Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. J Clin Oncol 2010;28:1308-1315.
28. Smith R, Pak Y, Kraybill W, et al. Factors associated with actual long-term survival following soft tissue sarcoma pulmonary metastasectomy. Eur J Surg Oncol 2009;35:356-361.
29. Kayton ML. Pulmonary metastasectomy in pediatric patients. Thorac Surg Clin 2006;16:167-183, vi.
30. Hacker FM, von Schweinitz D, Gambazzi F. The relevance of surgical therapy for bilateral and/or multiple pulmonary metastases in children. Eur J Pediatr Surg 2007;17:84-89.
31. Fuchs J, Seitz G, Ellerkamp V, et al. Analysis of sternotomy as treatment option for the resection of bilateral pulmonary metastases in pediatric solid tumors. Surg Oncol 2008;17:323-330.
32. Koscielniak E, Klingebiel TH, Peters C, et al. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian pediatric bone marrow transplantation group. Bone Marrow Transplant 1997;19:227-231.
33. Pappo AS, Lyden E, Breitfeld P, et al. Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: The children's oncology group. J Clin Oncol 2007;25:362-369.